Position in TRDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,410,542
-$812,165 QoQ
Shares Held
191,650
+8.8% QoQ
Ownership
0.492%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 128 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in TRDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. TRDA ranks #232 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in TRDA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,410,542 | 191,650 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,222,707 | 176,126 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,675,378 | 260,251 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $2,011,182 | 346,756 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $1,096,008 | 163,097 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $665,894 | 73,661 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,415,580 | 81,873 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,490,386 | 93,266 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $698,973 | 49,051 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,524,150 | 107,562 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $743,995 | 49,304 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $330,944 | 20,946 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $452,729 | 29,903 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $605,635 | 41,768 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $336,455 | 24,886 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $165,952 | 10,530 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $258,030 | 21,185 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $78,509 | 8,361 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $71,253 | 4,162 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||